Please ensure Javascript is enabled for purposes of website accessibility

4 Marijuana Stocks to Buy on 420 Day That Could Soar 20% or More This Year

By Keith Speights - Updated Apr 20, 2021 at 10:51AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

These high-flying pot stocks should have plenty of room to run.

None of the California students who originally connected 420 with cannabis use had a clue what they were starting. Today, 420 day -- April 20 -- is celebrated by many cannabis proponents. And they have more to celebrate this year than ever. New York, New Mexico, and Virginia recently passed legislation to legalize recreational marijuana, bringing the total number of states where pot is or will soon be legal to 17.

There are also more opportunities for investors to profit from the booming U.S. cannabis industry than ever before. In keeping with the 420 theme, here are four marijuana stocks to buy on 420 day that could realistically soar 20% or more this year.

A green traffic light with a cannabis leaf on the light.

Image source: Getty Images.

1. Ayr Wellness

Ayr Wellness (AYRW.F -0.80%) started out focusing on the cannabis markets in Massachusetts and Nevada. The company's scope is much bigger now. Thanks to acquisitions, Ayr now also operates in Arizona, Florida, Ohio, and Pennsylvania. 

There will soon be another state added to the list. Ayr plans to acquire Garden State Dispensary in a deal that will give it three cannabis dispensaries in New Jersey. This transaction is expected to close in the third quarter of 2021. 

With all of this gobbling up of smaller cannabis companies, Ayr will rank as a top-five multistate operator (MSO). It's also arguably the biggest bargain among its peers with the lowest price-to-sales (P/S) ratio in the industry. With its revenue growth set to accelerate, I think that Ayr stock could easily jump another 20% this year. 

2. Cresco Labs

Cresco Labs (CRLBF 4.20%) also ranks as one of the most attractively priced U.S. pot stocks with a P/S multiple only a little higher than Ayr's. Like Ayr, Cresco has grown tremendously through acquisitions.

The company is the largest cannabis wholesaler in the U.S. thanks to its early 2020 buyout of Origin House. It's a top cannabis wholesaler in California, Illinois, and Pennsylvania. The company also operates retail cannabis stores in the latter two states plus Arizona, Massachusetts, New York, and Ohio. 

All of these markets should give Cresco significant growth opportunities. Even better, Cresco's recent acquisition of Bluma Wellness will make the company a contender in Florida's booming medical cannabis market. New York's legalization of recreational marijuana also opens up a huge new market for Cresco. The company already is one of only 10 cannabis operators currently licensed for vertical operations in the state.

3. Curaleaf Holdings

Speaking of New York, Curaleaf Holdings (CURLF -0.99%) claims the No. 1 market share in the state's medical cannabis market. The company should be able to leverage that position to become a big winner in New York's recreational marijuana market as well.

Curaleaf stands as the largest MSO in the U.S. right now. And it's not just the market leader in New York. The company also holds leading market shares in Connecticut, Maryland, Massachusetts, New Jersey, North Dakota, Pennsylvania, and Vermont. In addition, it has a No. 2 or No. 3 retail market share in Arizona, Florida, and Maine.

There's no question that Curaleaf will be able to continue growing in the U.S. However, the company also now has a solid growth opportunity in Europe. Earlier this month, Curaleaf completed its acquisition of EMMAC, Europe's largest vertically integrated independent cannabis company. 

4. Jushi Holdings

Jushi Holdings (JUSHF 4.93%) is the smallest of these four cannabis stocks with a market cap of less than $700 million. However, Jushi is growing sales faster than most of its rivals. Its stock has also outperformed all of the biggest MSOs over the last 12 months. 

I think Jushi's share price has plenty of room to run. In March, the company opened its 17th retail cannabis store nationwide. Eleven of those stores are in Pennsylvania. Like its peers, Jushi is also growing via acquisitions. It recently closed deals in Massachusetts and Nevada. Earlier this year, the company signed two agreements that expand its operations in California.

Jushi appears to be poised to potentially be the biggest winner from Virginia's legalization of recreational marijuana. It already has a presence in the medical cannabis market in the fast-growing northern part of the state. Although Virginia's recreational market isn't scheduled to open until 2024, Jushi should have other growth drivers over the short term that could propel this stock 20% higher or more this year.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Jushi Holdings Inc. Stock Quote
Jushi Holdings Inc.
JUSHF
$1.49 (4.93%) $0.07
Curaleaf Holdings, Inc. Stock Quote
Curaleaf Holdings, Inc.
CURLF
$5.00 (-0.99%) $0.05
Cresco Labs Inc. Stock Quote
Cresco Labs Inc.
CRLBF
$2.60 (4.20%) $0.10
Ayr Wellness Inc. Stock Quote
Ayr Wellness Inc.
AYRW.F
$4.92 (-0.80%) $0.04

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
316%
 
S&P 500 Returns
112%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 07/04/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.